Photocatalytic degradation of pharmaceutical drugs and dyes using visible active biox photocatalyst

Patent metadata

Field	Value
Publication number	US-9409791-B2
Application number	US-201414584168-A
Country	US
Kind code	B2
Filing date	Dec 29, 2014
Priority date	Dec 29, 2014
Publication date	Aug 9, 2016
Grant date	Aug 9, 2016

Abstract

Provided is a visible active photocatalyst of formula BiOX wherein X=P or S and process of preparation and use thereof. Use of the catalyst is demonstrated in the photocatalytic degradation of pharmaceutical drug pollutants and pollutant dyes using solar radiation or artificial radiation.

First claim

I claim:

1. A visible active photocatalyst active in the visible and UV regions of the electromagnetic spectrum, of formula BiOX wherein X=P or S, said catalyst active for degradation of an organic compound.

2. The visible active photocatalyst according to claim 1 , wherein the photocatalyst is selected from the group consisting of BiOS and BiOP.

3. The visible active photocatalyst according to claim 1 in porous particle form.

4. The visible active photocatalyst according to claim 3 , wherein the photocatalyst is BiOS particles having a size in the range of from 80 nm to 240 nm, and a surface area in the range of 100 to 110.2 m 2 /g.

5. The visible active photocatalyst according to claim 3 , wherein a BiOS photocatalyst has an average pore size of 3.95 nm and an average pore volume of 0.109 cm 3 /g.

6. A process for the preparation of visible active photocatalyst active in the visible and UV regions of the electromagnetic spectrum, of formula BiOX wherein X=P or S, said process comprising steps of:
(a) adding bismuth (III) oxide to ethanol to form a mixture;
(b) stirring the mixture of step (a) and adding concentrated sulfuric acid or phosphoric acid at 40° C. to form a reaction mixture;
(c) sonicating the reaction mixture of step (b) for 1 hr; and
(d) calcining the sonicated product of (c) at 500° C. for 12 hrs. to produce the photocatalyst.

7. The process of claim 6 wherein the product of step (c) is washed with ethanol or deionized water or alternately with ethanol and with deionized water and vacuum dried before calcination.

8. A process of degrading at least one organic pollutant comprising: exposing the pollutant in liquid medium, the pollutant in a concentration range of 1-1000 ppm, to visible light of 400-800 nm wavelength in the presence of a photocatalyst of formula BiOX wherein X=P or S, said photocatalyst in a concentration range of 0.1-20 g/L for 1-24 hours to obtain a residual equilibrium concentration of pollutant in the range of 0.5-50 ppm.

9. The process of degradation according to claim 8 , wherein the process is carried out at pH in the range of 3 to 7.

10. The process of degradation according to claim 9 conducted at pH 7.

11. The process of degradation of a pollutant according to claim 8 , wherein said process comprises addition of at least one salt selected from the group consisting of sodium hydroxide, sodium carbonate, sodium bicarbonate, ferrous sulphate, copper sulphate, sodium chloride and ammonium sulphate.

12. The process of degradation of the pollutant according to claim 8 , wherein said pollutant is selected from the group consisting of a pharmaceutical compound and a dye.

13. The process of degradation of the pollutant according to claim 12 , wherein said pharmaceutical pollutant is selected from the group consisting of amoxicillin, azithromycin, bacitracin, ciprofloxacin hydrochloride, doxycycline, erythromycin, lincomycin, naproxen, penicillin G, penicillin V, sulfadiazine, sulfamethizole, sulfamethoxazole, tetracycline, trimethoprim, diclofenac, carbamazepine, atenolol, bezafibrate, lidocaine, clarithromycin, paracetamol, diatrizoate, iopamidol, iopromide, cyclophosphamide and ifosfamide.

14. The process of degradation of the pollutant according to claim 13 , wherein said pharmaceutical pollutant is ciprofloxacin hydrochloride or naproxen.

15. The process of degradation of a pollutant according to claim 12 , where in the dye is selected from the group consisting of Alizarin, Bismarck brown Y, Brilliant cresyl blue, Congo red, Crystal violet, Janus green, Lissamine fast yellow, Martius yellow, Meldola blue, Metanil yellow, Methyl orange, Methyl red, Naphthalene black 12B, Naphthol green B, Naphthol yellow S, Orange G, Rose Bengal, Sudan II, Titan yellow, Victoria blue 4R, Victoria blue B, and Victoria blue R.

16. The process of degradation of a pollutant according to claim 15 wherein the dye is an orange dye.

17. The process of degradation of an organic pollutant according to claim 8 , wherein the visible light source is solar radiation or artificial radiation.

Assignees

• Council Scient Ind Res

Inventors

• Kamble Sanjay Pandurang

Classifications

• B01J27/04

  Sulfides · CPC title

• C02F2101/36

  containing halogen · CPC title

• B01J27/186

  with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium · CPC title

• C01G29/00 Primary

  Compounds of bismuth · CPC title

• C02F2305/10

  Photocatalysts · CPC title